P&T Heart Failure

Syndicated P&T Session: Heart Failure

MMIT recently conducted a syndicated simulated P&T Heart Failure session focused on the entry Farxiga, and anticipated entry of Jardiance, into heart failure.

Learn how you can use P&T Perspectives to:

  • Gain an understanding of the impact of these agents in heart failure and how that might impact your brand.
  • Boost your brand by identifying the key differentiators and any unforeseen access barriers

Interested in obtaining the full video and learning more about how you can take advantage of P&T Perspectives?



Witness the Actual Discussions: